What is non-small cell lung cancer?

Non-small cell lung cancer (NSCLC) is a type of lung cancer in which cells in the lung grow abnormally and form a tumor. Lung cancers typically start in cells lining the bronchi and parts of the lung, such as the bronchioles or alveoli (Figure 1).

Figure 1. Human Respiratory System

Approximately 85% of lung cancers are NSCLC.

There are three main types of NSCLC (Figure 2).

  • Adenocarcinoma – is the most common type of NSCLC. It affects women more than men. Adenocarcinoma is usually found in the outer parts of the lung (alveoli) and is often found before it has spread to other parts of the lung or body.
  • Squamous cell carcinoma – this type of NSCLC starts in squamous cells, (which are flat cells that line the inside of the lungs airways. It tends to be found in the middle part of the lungs, near one of the main airways (bronchi). Patients with squamous cell carcinoma often have a history of smoking. This type of cancer tends to grow and spread to other parts of the body quickly.
  • Large cell (undifferentiated) carcinoma – this type of NSCLC can be found in any part of the lung. It tends to grow and spread quickly, which can make it hard to treat.
Figure 1. Human Respiratory System

All of the causes of lung cancer are not fully known. Some of the major risk factors are shown in Figure 3. Tobacco smoke is a known risk factor for lung cancer. Your risk for getting lung cancer is much higher if you have a history of smoking. Secondhand smoke is thought to cause more than 7,300 deaths from lung cancer each year among people who do not smoke. Of note, lung cancer can also occur in people who never smoked. Other risk factors for lung cancer include a family history of cancer or exposure to radon, asbestos, or air pollution. According to the US Environmental Protection Agency (EPA), radon is the second leading cause of lung cancer in the United States, and is the top cause of lung cancer in people who never smoked.

Figure 1. Human Respiratory System

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Search

[divi_global_search_form]

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Patient Journey

Patient Journey

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner